New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
ETF What's Up
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
XGEN
IE000KD0BZ68
XGEN ETF · Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF
The XGEN Exchange Traded Fund (ETF) is provided by Xtrackers by DWS. It is built to track an index: MSCI ACWI IMI Genomic Innovation Select Screened 100 Index. The XGEN ETF provides physical exposure, so by buying it you actually own parts of all the 99 underlying holdings. The dividend policy is capitalization.
Real-time data unavailable for XGEN
LIVE
CLOSED
This fund is part ofWorld Blended Cap1M perf.-3.65%
Last price
N/A
1M perf.
-5.50%
1M flows
N/A
AuM
€5.3M
E/R
0.3%
Rating
ESG Consensus®
XGEN
N/A
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
XGEN
$32.10
-8.32%
World Blended Cap
+0.97%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -5.50%  | -8.32% | +12.55% | +7.85% | N/A | -7.93% | -7.23% | -7.23% | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/12/2026
$32.10
1D NAV change
-2.85%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
99
Inception date
7/12/2022
Jurisdiction
Ireland
Distribution
Austria
United Kingdom
Italy
Ireland
Luxembourg
Legal structure
Open-end Investment Company
Base currency
USD
Classification
Product type
Benchmark
MSCI ACWI IMI Genomic Innovation Select Screened 100 Index
Asset class
Factors
N/A
Investment strategy
The fund is passively managed. The aim is for your investment to track the performance before fees and expenses of the MSCI ACWI IMI Genomic
Innovation Select ESG Screened 100 Index (index).
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
HTEC
1M perf.
-4.76%
E/R
0.8%
DOCG
1M perf.
-7.52%
E/R
0.49%
BMED
1M perf.
-6.03%
E/R
0.77%
2B78
1M perf.
-5.22%
E/R
0.4%
LIV
1M perf.
-0.93%
E/R
0.75%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -8.32% | +12.55%  | +7.85% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
77.25%
Switzerland
12.43%
Cayman Islands
4.80%
Netherlands
2.48%
Other
3.04%
Sectors
Health Care
88.18%
Unavailable
11.82%
Diversification
Total weight of top 15 holdings out of 99
Top 15 holdings
Data as of January 31, 2026
ROCHE
NATERA
VERTEX PHARMACEUTICALS
ILLUMINA
LILLY
DANAHER
LONZA GRP AG
AGILENT TECHNOLOGIES
Create a free account to view top holdings
ABBOTT LABS
INSMED
US04016X1019
MODERNA INC
MEDPACE HOLDINGS INC
WUXI BIOLOGICS (CAYMAN)
PERKINELMER
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
Yes
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about XGEN ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
XGEN’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
90.27% of holdings have positive scoring
9.73% of holdings have negative scoring
16.44%
56.84%
16.99%
7.91%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
MSCI ACWI IMI Genomic Innovation Select Screened 100 Index - USD
Index ticker
NU738645 Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Xtrackers by DWS
Xtrackers by DWS ID Card
Number of funds
490
Total AuM
€323.47B
Expense ratio range
0.03% - 0.95%
Average expense ratio
0.2452%
Top 5 funds by Xtrackers by DWS
| AuM | ||
|---|---|---|
XEON | Xtrackers II EUR Overnight Rate Swap UCITS ETF | €19.33B |
XDWD | Xtrackers MSCI World UCITS ETF | €16.51B |
XMME | Xtrackers MSCI Emerging Markets UCITS ETF | €9.66B |
XD9U | Xtrackers MSCI USA UCITS ETF | €9.25B |
XDEW | Xtrackers S&P 500 Equal Weight UCITS ETF | €9.22B |
Frequently asked questions about XGEN
What does Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF, XGEN, invest in?
XGEN is a Passive ETF. This ETF provides exposure to Other Equities.
Which benchmark or index does XGEN replicate?
XGEN tracks the MSCI ACWI IMI Genomic Innovation Select Screened 100 Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of XGEN?
XGEN carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.
When was XGEN launched?
XGEN was introduced to the market on July 12, 2022. It trades on Austria, among other exchanges
Who is the ETF issuer of XGEN?
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF, XGEN, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
What is the current assets under management (AUM) of XGEN?
XGEN oversees €5.3M in assets as of March 12, 2026.
How has XGEN performed lately?
Based on data from March 12, 2026, XGEN returned -5.50% over the past month, -8.32% over the last three months and -7.23% year-to-date.
Does XGEN distribute dividends?
XGEN follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of XGEN?
As of January 31, 2026, XGEN has significant geographic allocations in USA, Switzerland and Cayman Islands.
In which sector or theme does XGEN invest in?
As of January 31, 2026, XGEN focuses largely on Health Care.
How many securities does XGEN hold and how diversified is it?
As of January 31, 2026, XGEN holds 99 positions in its portfolio, with 57.01% of assets concentrated in its top 15 holdings.
What are the main positions in XGEN?
As of January 31, 2026, XGEN top three holdings include ROCHE, NATERA and VERTEX PHARMACEUTICALS.
What is the base currency of XGEN?
The base currency of XGEN is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
